Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Sell
6,153
-107
-2% -$36.6K 0.39% 46
2026
Q1
$2.2M Buy
6,260
+7
+0.1% +$2.5K 0.49% 47
2025
Q4
$2.05M Sell
6,253
-15
-0.2% -$4.76K 0.48% 47
2025
Q3
$1.77M Buy
6,268
+277
+5% +$80.3K 0.43% 51
2025
Q2
$1.67M Buy
5,991
+107
+2% +$30.3K 0.46% 50
2025
Q1
$1.83M Buy
5,884
+2,128
+57% +$628K 0.62% 35
2024
Q4
$1.21M Hold
3,756
0.39% 64
2024
Q3
$1.21M Buy
3,756
+143
+4% +$46.8K 0.39% 65
2024
Q2
$1.13M Buy
3,613
+282
+8% +$82.8K 0.39% 59
2024
Q1
$947K Buy
3,331
+372
+13% +$109K 0.35% 71
2023
Q4
$852K Buy
2,959
+46
+2% +$12.5K 0.36% 73
2023
Q3
$783K Buy
2,913
+301
+12% +$75.1K 0.37% 71
2023
Q2
$580K Sell
2,612
-2
-0.1% -$464 0.28% 99
2023
Q1
$632K Buy
2,614
+100
+4% +$24.5K 0.33% 86
2022
Q4
$660K Buy
+2,514
New +$674K 0.38% 80

Other funds holding AMGN

Chapin Davis's AMGN Position: Q2 2026 in Review

Chapin Davis reduced its Amgen (AMGN) stake by 1.7% in Q2 2026, selling an estimated $36.6K and leaving 6,153 shares worth $2.23M. The position accounts for 0.39% of the portfolio, ranked #46.

Chapin Davis first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Chapin Davis held 6,153 shares of Amgen worth $2.23M as of Q2 2026.
  • Chapin Davis sold 107 Amgen shares in Q2 2026, an estimated $36.6K.
  • Amgen made up 0.39% of Chapin Davis's portfolio in Q2 2026, its #46 holding.
  • Chapin Davis first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.